KORU Medical Systems, Inc.
KRMD Healthcare Medical Instruments & Supplies
KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow KRMD
KORU Medical Systems, Inc. (KRMD) Altman Z-score
KORU Medical Systems, Inc.'s Altman Z-score for fiscal 2025 is 14.46, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 14.46 | 4.82 |
| FY2024 | 9.64 | 2.02 |
| FY2023 | 7.62 | (1.29) |
| FY2022 | 8.91 | (8.69) |
| FY2021 | 17.59 | (24.31) |
| FY2020 | 41.91 | (18.64) |
| FY2019 | 60.54 | 33.29 |
| FY2018 | 27.26 | 6.41 |
| FY2017 | 20.85 | 11.97 |
| FY2017 | 8.88 | (4.12) |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.42 | — | 0.50 | |
| Retained earnings / total assets | (1.14) | — | −1.59 | |
| EBIT / total assets | (0.11) | — | −0.35 | |
| Market value of equity / total liabilities | 24.06 | — | 14.44 | |
| Sales / total assets | 1.46 | — | 1.46 | |
| Altman Z-score | Safe zone | 14.46 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −0.06 | ||
Z and Z″ put KORU Medical Systems, Inc. in different zones: safe zone by Z, distress zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| UTMD Utah Medical Products, Inc. compare | 36.3× |
| KRMD KORU Medical Systems, Inc. | 14.5× |
| PDEX Pro-Dex, Inc. compare | 7.4× |
| SMTI Sanara MedTech Inc. compare | 2.3× |
| OSUR OraSure Technologies, Inc. compare | 1.5× |
| ZTEKF Zentek Ltd. compare | −2.1× |
| NYXH Nyxoah SA compare | −4.4× |
| STXS Stereotaxis Inc. compare | −12.4× |
| MBOT Microbot Medical Inc. compare | −19.4× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets